Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) and the Peking University School of Public Health have officially initiated public health projects aimed at training young and middle-aged backbone talent. This collaboration seeks to enhance the skills and knowledge of professionals in the public health sector, contributing to the development of a robust healthcare workforce.
MSD’s Business Presence in China
MSD’s business presence in China is extensive, covering vaccines, diabetes, in-hospital specialty medicines, and oncology, among other specialty areas. The US-based company has its headquarters in Shanghai, a research and development center in Beijing, and manufacturing facilities in Hangzhou, Ningbo, and Tianjin. This strategic footprint allows MSD to effectively support public health initiatives and contribute to the advancement of healthcare in China.-Fineline Info & Tech
